Germany, Spain, and Italy have the most developed regulatory frameworks for investigational stem-cell therapies, with several university hospitals and private institutes conducting registered trials in muscular dystrophy. Poland and Czech Republic also offer active research programmes with lower cost structures. The United States has limited clinical trial capacity for muscular-dystrophy-specific stem-cell work, though the NIH and several academic centres maintain ongoing studies. United Kingdom access is primarily through National Health Service research protocols or private pay clinics. Choosing a centre should prioritise registration with ClinicalTrials.gov or EudraCT and publication of prior safety data.
Muscular dystrophy treatment costs typically range €4,000–7,500 per cycle, reflecting the need for multiple infusions and specialist neuromuscular assessment. Placental MSC sourcing and expansion for systemic administration incurs higher manufacturing expense than single-injection protocols. Disease severity and muscle group involvement influence whether local or systemic delivery is elected, affecting total cost. Many programmes require baseline and follow-up neuroimaging and strength testing, adding to overall expenses. European centres generally charge at the lower end of the range for research-protocol participation, whilst private clinics may exceed €8,000 per session.
我是候选人吗？ → · Muscular Dystrophy: full overview → · 肌肉营养不良成本 → · Cost →
由 StemCellAtlas 的编辑团队进行医学审查，与Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) 合作诊所 Stem Plus（索菲亚）的，根据 ISSCR、FDA 和 EMA 指南。 Educational information, not medical advice; figures indicative.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估